Insulin resistance alters hepatic ethanol metabolism: Studies in mice and children with non-alcoholic fatty liver disease

Gut

Volumn 65, Issue 9, 2016, Pages 1564-1571

  Engstler, Anna Janina ^a   Aumiller, Tobias ^b   Degen, Christian ^a   Dürr, Marion ^a   Weiss, Eva ^b   Maier, Ina Barbara ^b   Schattenberg, Jörn Markus ^c   Jin, Cheng Jun ^a   Sellmann, Cathrin ^a   Bergheim, Ina ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF HOHENHEIM   (Germany)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Bacterial overgrowth; ethanol; fatty liver; TNF alpha

Indexed keywords

ALCOHOL; ALCOHOL DEHYDROGENASE; CYTOCHROME P450 2E1;

ALCOHOL BLOOD LEVEL; ALCOHOL METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAVA VEIN; CHILD; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; INSULIN RESISTANCE; LIVER METABOLISM; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PARENCHYMA; PORTAL VEIN; PRIORITY JOURNAL; ANIMAL; BLOOD; BODY MASS; CLINICAL TRIAL; LIVER; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; NUTRITION; PHYSIOLOGY; PRESCHOOL CHILD; STATISTICS;

ALCOHOL DEHYDROGENASE; ANIMALS; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; CYTOCHROME P-450 CYP2E1; ETHANOL; FEMALE; HUMANS; INSULIN RESISTANCE; LIVER; MALE; MICE; NON-ALCOHOLIC FATTY LIVER DISEASE; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; STATISTICS AS TOPIC;

EID: 84985995579     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2014-308379     Document Type: Article

References (42)

1. Olufadi R, Byrne CD. Clinical and laboratory diagnosis of the metabolic syndrome. J Clin Pathol 2008;61:697-706.
2. Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004;350:2362-74.
3. Moschen AR, Tilg H. Nutrition in pathophysiology and treatment of nonalcoholic fatty liver disease 3. Curr Opin Clin Nutr Metab Care 2008;11:620-5.
4. Duseja A, Chawla YK. Obesity and NAFLD: the role of bacteria and microbiota. Clin Liver Dis 2014;18:59-71.
5. Wagnerberger S, Spruss A, Kanuri G, et al. Toll-like receptors 1-9 are elevated in livers with fructose-induced hepatic steatosis. Br J Nutr 2012;107:1727-38.
6. Wong VW, Tse CH, Lam TT, et al. Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis-a longitudinal study. PLoS ONE 2013;8:e62885.
7. Zhu L, Baker SS, Gill C, et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology 2013;57:601-9.
8. Kanuri G, Ladurner R, Skibovskaya J, et al. Expression of toll-like receptors 1-5 but not TLR 6-10 is elevated in livers of patients with non-alcoholic fatty liver disease. Liver Int 2015;35:562-8.
9. Vajro P, Paolella G, Fasano A. Microbiota and gut-liver axis: their influences on obesity and obesity-related liver disease. J Pediatr Gastroenterol Nutr 2013;56:461-8.
10. Nair S, Cope K, Risby TH, et al. Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis. Am J Gastroenterol 2001;96:1200-4.
11. Volynets V, Kuper MA, Strahl S, et al. Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD). Dig Dis Sci 2012;57:1932-41.
12. Cope K, Risby T, Diehl AM. Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis. Gastroenterology 2000;119:1340-7.
13. Arteel GE. Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology 2003;124:778-90.
14. Kromeyer-Hauschild K, Wabitsch M, Kunze D, et al. Percentile of body mass index in children and adolescents evaluated from different regional German studies. Monatsschr Kinderheilkd 2001;149:807-18.
15. Joseph AE, Saverymuttu SH, al-Sam S, et al. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 1991;43:26-31.
16. Maier IB, Ozel Y, Engstler AJ, et al. Differences in the prevalence of metabolic disorders between prepubertal boys and girls from 5 to 8 years of age. Acta Paediatr 2014;103:e154-60.
17. Weiß J, Rau M, Geier A. Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatment. Dtsch Arztebl Int 2014;111:447-52.
18. Bode C, Bode JC. Effect of alcohol consumption on the gut. Best Pract Res Clin Gastroenterol 2003;17:575-92.
19. Adachi Y, Moore LE, Bradford BU, et al. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 1995;108:218-24.
20. Blomstrand R. Observations of the formation of ethanol in the intestinal tract in man. Life Sci II 1971;10:575-82.
21. Sarkola T, Eriksson CJ. Effect of 4-methylpyrazole on endogenous plasma ethanol and methanol levels in humans. Alcohol Clin Exp Res 2001;25:513-16.
22. Baraona E, Julkunen R, Tannenbaum L, et al. Role of intestinal bacterial overgrowth in ethanol production and metabolism in rats. Gastroenterology 1986;90:103-10.
23. Alkhouri N, Cikach F, Eng K, et al. Analysis of breath volatile organic compounds as a noninvasive tool to diagnose nonalcoholic fatty liver disease in children. Eur J Gastroenterol Hepatol 2014;26:82-7.
24. Saad RJ, Chey WD. Breath testing for small intestinal bacterial overgrowth: maximizing test accuracy. Clin Gastroenterol Hepatol 2014;12:1964-72.
25. Sachdev AH, Pimentel M. Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance. Ther Adv Chronic Dis 2013;4:223-31.
26. Khoshini R, Dai SC, Lezcano S, et al. A systematic review of diagnostic tests for small intestinal bacterial overgrowth. Dig Dis Sci 2008;53:1443-54.
27. Rana SV, Bhardwaj SB. Small intestinal bacterial overgrowth. Scand J Gastroenterol 2008;43:1030-7.
28. Gu S, Chen D, Zhang JN, et al. Bacterial community mapping of the mouse gastrointestinal tract. PLoS ONE 2013;8:e74957.
29. Ley RE, Backhed F, Turnbaugh P, et al. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 2005;102:11070-5.
30. Seitz HK, Xu Y, Simanowski UA, et al. Effect of age and gender on in vivo ethanol elimination, hepatic alcohol dehydrogenase activity, and NAD+ availability in F344 rats. Res Exp Med (Berl) 1992;192:205-12.
31. Feuers RJ, Duffy PH, Leakey JA, et al. Effect of chronic caloric restriction on hepatic enzymes of intermediary metabolism in the male Fischer 344 rat. Mech Ageing Dev 1989;48:179-89.
32. Mezey E, Potter JJ, Rhodes DL. Effect of growth hormone on alcohol dehydrogenase activity in hepatocyte culture. Hepatology 1986;6:1386-90.
33. Mezey E, Potter JJ, Mishra L, et al. Effect of insulin-like growth factor I on rat alcohol dehydrogenase in primary hepatocyte culture. Arch Biochem Biophys 1990;280:390-6.
34. Lakshman MR, Chambers LL, Chirtel SJ, et al. Roles of hormonal and nutritional factors in the regulation of rat liver alcohol dehydrogenase activity and ethanol elimination rate in vivo. Alcohol Clin Exp Res 1988;12:407-11.
35. Leclercq IA, Field J, Enriquez A, et al. Constitutive and inducible expression of hepatic CYP2E1 in leptin-deficient ob/ob mice. Biochem Biophys Res Commun 2000;268:337-44.
36. Mantena SK, Vaughn DP, Andringa KK, et al. High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo. Biochem J 2009;417:183-93.
37. Cederbaum AI, Wu D, Mari M, et al. CYP2E1-dependent toxicity and oxidative stress in HepG2 cells. Free Radic Biol Med 2001;31:1539-43.
38. Hernandez I, Dominguez-Perez M, Bucio L, et al. Free fatty acids enhance the oxidative damage induced by ethanol metabolism in an in vitro model. Food Chem Toxicol 2015;76:109-15.
39. Bergheim I, Guo L, Davis MA, et al. Metformin prevents alcohol-induced liver injury in the mouse: critical role of plasminogen activator inhibitor-1. Gastroenterology 2006;130:2099-112.
40. Alatalo PI, Koivisto HM, Hietala JP, et al. Effect of moderate alcohol consumption on liver enzymes increases with increasing body mass index. Am J Clin Nutr 2008;88:1097-103.
41. Diehl AM. Obesity and alcoholic liver disease. Alcohol 2004;34:81-7.
42. Bonfrate L, Grattagliano I, Palasciano G, et al. Dynamic carbon 13 breath tests for the study of liver function and gastric emptying. Gastroenterol Rep (Oxf ) 2015;3:12-21.